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1The serine/threonine kinase mammalian target of rapamycin (mTOR) is ubiquitously expressed and exists in 2 multipro-
tein complexes, mTOR complex 1 (mTORC1) and complex 2 
(mTORC2).1,2 The rapamycin-insensitive companion of mTOR 
(RICTOR) is essential for the role of mTORC2 in propagat-
ing phosphoinositid-3-kinase elicited signals originating from 
hormones and growth factors.2,3 mTORC2 phosphorylates and 
activates members of the AGC kinase family, such as AKT.4 
Adipocyte-specific ablation of Rictor results in higher lean mass 
because of increased levels of insulin and insulin-like growth 
factor -1, enhanced glucose metabolism, and insulin resistance 
in mice.5,6 Using this mouse model, we have recently shown 
that vascular reactivity of the thoracic aorta with perivascular 
adipose tissue (PVAT) is altered and levels of inflammatory 
molecules in the PVAT are elevated.7 However, the specific-
ity of adipocyte protein-2 (aP2) gene promoter–driven CRE 
recombinase expression for adipose tissue, an approach which 
was used for all above-mentioned studies, may vary and affect 
other tissues.8 Consequently, target gene expression data from 
different organs should be considered for interpretation. In this 
study, we refer to these mice as RictoraP2KO mice.
In a healthy condition, PVAT releases vasoactive mol-
ecules conferring anticontractile properties to PVAT.9 In 
obesity, PVAT’s secretory profile changes to favor a proin-
flammatory state compromising PVAT’s anticontractile prop-
erties.10 Impaired PVAT function contributes to alterations in 
vascular reactivity which manifests itself in blood pressure 
changes as observed previously in a rat model of hyperten-
sion.11 Intriguingly, inflammation is present in the vascula-
ture in animal models of hypertension,12,13 which supports the 
idea that inflammation of PVAT might play a significant role 
in the development of hypertension. The key characteristics 
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of essential hypertension are hyperactivation of the renin–
angiotensin aldosterone system and the sympathetic nervous 
system.14 These 2 systems are also under the control of the 
circadian clock,15 which is not surprising considering the diur-
nal fluctuations in blood pressure. Clock genes are part of a 
hierarchically organized circadian clock system in which the 
suprachiasmatic nucleus (SCN) in the hypothalamus serves 
as a master clock.16 The SCN is entrained by the light/dark 
cycle and transmits humoral and neural signals to synchronize 
peripheral clocks located in most tissues, including the heart, 
adipose tissue, and blood vessels.15
In this study, we examined whether the increase in aortic 
contractility because of impaired PVAT function, which we 
reported previously, translates into elevated blood pressure.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Mean Arterial Pressure Is Increased and Its 
Physiological Decline Nearly Absent in RictoraP2KO 
Mice
To investigate whether the increased aortic contractility 
which we observed previously in RictoraP2KO mice7 trans-
lates into higher blood pressure, hemodynamic parameters 
were recorded using radiotelemetry. The 24-hour average of 
mean arterial pressure (MAP, Figure 1B, left panel; Table 
S1 in the online-only Data Supplement) and diastolic arte-
rial pressure (Table S1) were increased in RictoraP2KO mice 
(+5.4 and +4.4 mm Hg, respectively; P<0.05), whereas sys-
tolic arterial pressure displayed an upward trend (P=0.08; 
Table S1) compared with control mice. Pulse pressure was 
similar between groups (Table S1). To determine diurnal 
patterns of MAP in RictoraP2KO and control mice, we ana-
lyzed data obtained from a telemetric measurement >7 
days. Both groups displayed diurnal rhythmicity of MAP 
(Figure 1A, left panel). A detailed analysis for day 5 is 
shown in Figure 1A (right panel). However, the physi-
ological decline of MAP in RictoraP2KO mice during the sec-
ond half of the dark period appeared to be nearly absent 
(Figure 1A). Therefore, we analyzed MAP during the first 
and second half of the dark period separately. MAP was not 
significantly different during the first half of the dark period 
(Figure 1B, gray shaded area). Although decreasing sig-
nificantly during the second half only in controls (P<0.05), 
MAP remained high in RictoraP2KO mice (Figure 1B, gray 
shaded area). The Pearson correlation coefficient between 
time and MAP values during the second half of the dark 
period for control and RictoraP2KO mice had median values of 
−0.3 and 0, respectively (Figure 1C). This suggests that the 
decline in MAP during the second half of the dark period 
is nearly absent in RictoraP2KO mice. In the first half of the 
light period, MAP values were different between groups 
(P<0.05), whereas MAP levels were similar in the second 
half, showing a steady increase with highest values at the 
transition to the dark period (Zeitgeber time [ZT]12/7:00 
pm; Figure 1B). A detailed analysis of the diastolic arterial 
pressure, systolic arterial pressure, and heart rate (HR) for 
day 5 revealed that these blood pressure parameters fol-
lowed similar patterns as MAP (Figure 1D).
Impaired Decline of Locomotor Activity During 
the Dark Period and Overall Hyperactivity in 
RictoraP2KO Mice
Locomotor activity is an important parameter that could 
account for the observed changes in blood pressure regula-
tion.17 In both mouse groups, the intensity of locomotor activity 
followed a diurnal pattern (Figure 2A). In control mice, loco-
motor activity peaked at the beginning of the dark period and 
gradually decreased as the dark period progressed. During the 
light period, only low activity was observed (Figure 2A, upper 
panel) in these mice. Interestingly, in the second half of the dark 
period, RictoraP2KO mice had a tendency to maintain high loco-
motor activity (Figure 2A, lower panel, grey shaded areas: 1:00 
to 7:00 am), which appeared to continue intermittently as indi-
cated by the spikes during the light period (Figure 2A, lower 
panel). A detailed analysis for day 5 is shown in Figure 2B. 
Next, we quantified overall activity data collected during the 
telemetric measurements. During the light and dark peri-
ods, RictoraP2KO mice displayed a strong trend toward higher 
intensity of activity (light, P=0.082; dark, P=0.18; Table S2). 
Interestingly, the percentage of time during which mice show 
activity,17 an alternative measure for locomotor activity, was 
increased in RictoraP2KO mice compared with controls during a 
24-hour cycle (Figure 2D; Table S2). Analyzing the light and 
the dark periods separately, we observed a significant increase 
in the time during which RictoraP2KO mice show activity com-
pared with controls (Table S2). During the dark period, this 
increase was remarkably more pronounced.
Differences in HR during the dark period amounted to +50 
and +19 BPM during light period in RictoraP2KO mice com-
pared with controls (Table S1; P<0.05). Similarly to MAP, 
HR remained high during the progression of the dark period 
(Figure S1). To visualize the similar patterns of MAP, HR, 
and locomotor activity during the dark period, these param-
eters were plotted in a single diagram displaying intensity of 
activity and MAP or HR, using 2 different y-axes (Figure S2A 
and S2B). The curves for the intensity of activity were highly 
similar to those for MAP and HR within the groups.
aP2 Promoter-Driven CRE Expression Ablates 
Rictor in Adipocytes and Brain
To confirm deletion of Rictor in adipocytes in our current set of 
RictoraP2KO mice, we measured mRNA expression levels in PVAT 
using quantitative real time–PCR. Steady-state mRNA expres-
sion levels of Rictor were reduced by 59% in PVAT, whereas 
they were similar in the aortic tissue between mouse groups 
(Figure 3A). As adipose tissue consists not only of adipocytes, 
but also other cells referred to as stromal vascular fraction, we 
separated adipocytes from stromal vascular fraction. In adipo-
cytes from epididymal adipose tissue of RictoraP2KO mice, Rictor 
expression was decreased by 58%, whereas similar levels were 
measured in control and knockout stromal vascular fractions 
(Figure 3A). Further analysis of Rictor mRNA expression levels 
revealed no differences in the heart, kidney, liver, monocytes, 
and T cells between groups (Figure 3A). Interestingly, Rictor 
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mRNA levels were decreased in the brain (SCN by 76%; cortex 
by 66%, Figure 3A). Collectively, these data suggest that Rictor 
is specifically ablated in the adipocytes and brain, whereas stro-
mal vascular fraction and aortic tissue were not affected.
We further characterized the impact of Rictor deletion in 
PVAT and brain. Histological examination of cross-sections 
of thoracic aortas with PVAT revealed higher perivascular cell 
density in RictoraP2KO mice compared with controls (Figure 3B, 
right panel). Consistently, the number of nuclei was 57% 
higher in PVAT from RictoraP2KO mice (P<0.01; Figure 3B). 
Brains of RictoraP2KO mice appeared smaller (Figure 3C, left 
panel), and absolute brain weight was decreased by 17% com-
pared with controls (Figure 3C, right panel).
Evidence of Mild Cardiomyocyte Hypertrophy  
in RictoraP2KO Mice
Next, we performed morphological assessment of the heart 
to evaluate the presence of possible hypertrophic changes. 
Mean absolute heart weights were higher in RictoraP2KO mice 
(Figure 4A), whereas mean relative to body heart weights 
were not changed compared with controls (Figure 4A). Right 
ventricular free wall and interventricular septal thickness were 
increased in RictoraP2KO mice (P=0.09 and P=0.08, respec-
tively, Figure 4A). The hearts of RictoraP2KO mice exhibited 
histological changes consistent with mild cardiomyocyte 
hypertrophy, as indicated by a 25% increase in the cardio-
myocyte cross-sectional area (Figure 4B, P<0.01). Staining 
Figure 1. Mean arterial pressure (MAP) is increased and its physiological decline is strongly impaired in Rictor knockout (RictoraP2KO) mice. 
A (left), Diurnal fluctuations of MAP are represented as 1 hour running median in RictoraP2KO and control mice. The 12:12 hour light/dark 
cycle is schematically depicted as white and black bars, respectively (light was switched on at Zeitgeber time (ZT) 0: 7:00 am; light off: 
7:00 pm/ZT12). A (right), MAP values are represented as hourly means±SEM on day 5. The gray shaded area denotes the dark period. B, 
MAP measurements were analyzed during 24 hours, for the first and second half of the light and dark periods, separately. The median 
is indicated as a horizontal line. C, MAP drops in control, but not in RictoraP2KO mice during the second half relative to the first half of the 
dark period. D, Diastolic and systolic arterial pressure and heart rate were analyzed in the conditions outlined in A. n=5/6. *P<0.05 and 
**P<0.01 vs control; ns indicates nonsignificant.
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with Masson’s trichrome revealed no evidence of fibrosis in 
the myocardium (data not shown). As it has been shown that 
RictoraP2KO mice exhibit increased organ size,5 we suspect that 
increased absolute heart weights and mild enlargement of the 
cardiomyofibres are most likely because of the overall phe-
notype, rather than to a compensatory change secondary to 
the only mild increase in blood pressure. In addition, there 
were no findings consistent with vascular remodeling second-
ary to hypertension,18 such as narrowing of the lumen, medial 
hypertrophy or increased adventitial fibrosis in the aorta or in 
the renal and pulmonary small and large arteries of RictoraP2KO 
mice (Figure S3 and data not shown). Representative cross-
sections of heart, kidney, and aortic arch are shown in Figure 
S3. Interestingly, gene expression levels of cardiac hyper-
trophy biomarkers were decreased in the heart of RictoraP2KO 
mice: atrial natriuretic peptide (NP) was decreased by 52% 
(P<0.05), whereas brain NP and β-myosin heavy chain 
showed a strong downwards trend (Figure 4C, left panel). The 
NPs bind to the transmembrane high affinity NP receptors 
NPR1, NPR2, and NPR3.19 These receptors are expressed in 
adipocytes to regulate adipose tissue metabolism, including 
lipolysis and adipokine secretion.19 Npr2 and Npr3 mRNA 
expression levels were decreased in adipocytes isolated from 
epididymal adipose tissue by 51% and 45%, respectively 
(Figure 4C, middle panel). A similar expression pattern of NP 
receptors was measured in PVAT (Figure 4C, right panel). In 
contrast, the Anp gene expression was nearly absent in PVAT.
Higher Insulin Levels and Variations  
in RictoraP2KO Mice
In previous studies using aP2 gene promoter–driven CRE 
recombinase to knockout Rictor in mice,5,6 diurnal fluctua-
tions of insulin were not investigated. Therefore, we measured 
insulin levels every 4 hours during a 24-hour cycle (Figure 
S4A). Insulin levels were higher at the beginning of the light 
period at ZT2 (9:00 am), and a trend toward higher insulin 
levels could also be observed during the dark period at ZT14 
(9:00 pm) and ZT18 (1:00 am; Figure S4A). Overall, levels 
of insulin varied 7.6-fold during a 24-hour cycle, whereas in 
controls only a 1.6-fold variation was quantified (Figure S4A). 
Figure 3. aP2/CRE-driven deletion of Rictor decreases expression 
of Rictor in adipocytes and brain. A, Steady-state mRNA 
expression levels of Rictor were determined using quantitative 
RT-PCR in Rictor knockout (RictoraP2KO) and control mice. Values 
are expressed in arbitrary units (AU). Perivascular adipose tissue 
(PVAT): n=8, aortas: n=7/8, epididymal adipose tissue (EFAT): 
n=8/9, adipocyte fraction (AF): n=7/11, stromal vascular fraction 
(SVF): n=4, T cells and monocytes: n=2/4, heart and kidney: n=7/8, 
liver: n=3, suprachiasmatic nucleus (SCN): n=3/5, and cortex: 
n=3/5. B, Cross-sections of thoracic aortas with PVAT from control 
and RictoraP2KO mice stained with hematoxylin/eosin (upper, black 
bar: 100 μm), and Hoechst (lower, white bar: 50 μm). Arrowheads 
indicate the thoracic aorta. Cell density of the perivascular tissue 
was determined by counting Hoechst-stained nuclei (n=5). C, 
Representative photographs of brains and quantification of 
absolute brain weight from each genotype (n=7/8). Values are 
means±SEM. **P<0.01, ***P<0.005, and ****P<0.001 vs control.
Figure 2. Intensity of activity and active time are increased in 
Rictor knockout (RictoraP2KO) mice. A, Values plotted represent the  
1 hour running median of the intensity of activity for control and 
RictoraP2KO mice. The black bars at the bottom indicate the 12 hour 
dark period and the grey shaded areas correspond to the second 
half of the dark period in RictoraP2KO and control, respectively. B, 
Locomotor activity measurements were analyzed during 24 hour 
on day 5. The gray shaded area indicates the dark period. Values 
are means±SEM. C, Intensity of activity and (D) active time during 
a 24-hour cycle are represented. The median for each group is 
indicated as a horizontal line. n=5/6. *P<0.05 vs control.
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Glucose levels in serum were significantly higher at the end of 
the light period (ZT10; 5:00 pm) followed by a sharp decline at 
ZT14 in RictoraP2KO mice, indicating that higher insulin levels 
might lead to decreased glucose plasma levels at the beginning 
of the dark period. (Figure S4B).
Identification of Differentially Expressed Genes in 
PVAT of RictoraP2KO Mice
Data from blood pressure and locomotor activity analyses 
revealed a complex phenotype in the RictoraP2KO mice which 
could not be explained solely by the induction of proinflam-
matory molecule expression in PVAT. To identify differentially 
expressed genes in PVAT of RictoraP2KO mice, we performed a 
microarray analysis. Gene Ontology analysis of differentially 
expressed genes (Table S4) revealed the circadian rhythm as the 
most affected pathway in PVAT (Table S3). The data have been 
deposited in GEO database (Accession Number: GSE67077).
Divergent Clock Gene Expression in PVAT,  
But Not in the Suprachiasmatic Nucleus, in 
RictoraP2KO Mice
To further examine the impact of Rictor deletion on clock 
genes, we analyzed mRNA expression levels of core clock 
genes Bmal1, Clock, Npas2, Cry1/2, Per1/2, Rev-Erb-alpha 
(Rev-Erb-α), and Rorα during a 24-hour cycle in PVAT and 
in aortic tissue (Figure 5 and Figure S5, respectively). In aor-
tic tissue, mRNA expression levels were mostly comparable 
between mouse groups and followed similar diurnal patterns 
(Figure S5). In PVAT, expression of Clock, Cry1, Per1, and 
Rorα was lower only during the light period in RictoraP2KO 
mice compared with controls (Figure 5). For Per2, a phase-
shift at the transition from the light to the dark periods was 
observed. Collectively, these data suggest that ablation of 
Rictor in adipocytes strongly affects clock gene expression in 
PVAT, but has only minimal effects on these genes in the aor-
tic tissue. We found that the circadian rhythm of blood pres-
sure (Figure 1) and locomotor activity (Figure 2) is altered in 
RictoraP2KO mice. Thus, we quantified clock gene expression in 
the SCN during a 24-hour cycle. No differences in the mRNA 
expression levels of Bmal1, Npas2, Clock, Cry1/2, Per1/2, 
Rev-Erb-α, and Rorα were detected between mouse groups 
(Figure 6). Collectively, these findings indicate that decreased 
Rictor expression in the SCN does not affect core clock gene 
expression, whereas expressional changes of Clock, Rorα, 
Per1/2, and Cry1 in PVAT are likely to contribute to increased 
blood pressure observed in RictoraP2KO mice.
Figure 4. Mild cardiomyocyte hypertrophy and decreased gene expression of natriuretic peptides and their receptors in Rictor knockout 
(RictoraP2KO) mice. A, Quantification of total heart weight, heart weight relative to body weight, left ventricle (LV), right ventricle (RV), and 
interventricular septum (IVS) thickness. n=7/8. B, Representative images of heart tissue stained with Periodic acid–Schiff reaction (white 
bar: 50 μm) and quantification of cardiomyocyte area. C, Steady-state mRNA expression levels of indicated genes were determined in 
heart (left, n=7/8), in adipocytes from epididymal adipose tissue (middle, n=6/7), and in perivascular adipose tissue (PVAT; right, n=3) 
using quantitative RT-PCR. Values are expressed in arbitrary units (AU). *P<0.05 and **P<0.01 vs control. Anp indicates atrial natriuretic 
peptide; Bnp, brain natriuretic peptide; Cnp, C-type natriuretic peptide; Mhc, myosin heavy chain; and Npr, natriuretic peptide receptor.
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Discussion
This is the first study to show that RICTOR/mTORC2 acts as a 
regulator for coordinated diurnal expression of clock genes in 
PVAT, but not in the SCN. At the whole body level, RICTOR/
mTORC2 in adipose and brain tissue contributes to the diur-
nal regulation of blood pressure and locomotor activity. The 
presented data demonstrate the importance of the mTORC2 
signaling pathway in the brain to adipocyte axis for daily fluc-
tuations of physiological processes.
We and others have recently shown that mTORC2 activ-
ity controls inflammatory molecule expression using tissue-
specific Rictor knockout mouse models.7,20 We showed that 
vascular contractility in RictoraP2KO mice is increased because 
of enhanced secretion of proinflammatory cytokines in 
PVAT.7 Ablation of Rictor strongly reduced AKTSer473 phos-
phorylation, resulting in impaired mTORC2 signaling.5–7 
Consequently, we assign the observed changes in RictoraP2KO 
mice to the impaired mTORC2 downstream signaling.
In this study, we explored these findings further by 
studying blood pressure regulation in RictoraP2KO mice. In 
line with our hypothesis, RictoraP2KO mice showed increased 
MAP and alterations of its diurnal patterns. The increase in 
blood pressure parameters was too small to be considered as 
hypertension. In fact, our observations rather point toward 
a phenotype in RictoraP2KO mice which is termed prehyper-
tension in patients.21 The term prehypertension is defined as 
blood pressure levels of 120 to 139 mm Hg for systolic and 
80 to 89 mm Hg for diastolic blood pressure, respectively.21 
Applying this definition to mice, we established a prehy-
pertensive phenotype in the RictoraP2KO mice. At the tissue 
level, we found that cell density of thoracic PVAT, shown to 
be highly similar to brown adipose tissue,22 is increased in 
RictoraP2KO mice. Intriguingly, it has been demonstrated that 
perivascular cell density is increased in an animal model of 
hypertension,11 and that adipocytes in brown adipose tissue 
lacking Rictor are smaller.23 This led us to speculate that ele-
vated blood pressure is at least partially linked to the higher 
cell density in PVAT of RictoraP2KO mice.
NPs are hormonal regulators of vasodilation and natriure-
sis lowering blood pressure.24 We report that Anp and Bnp 
mRNA expression levels are reduced in hearts of RictoraP2KO 
mice. Our results obtained in mice are in agreement with the 
findings in a study with patients showing that a prehyperten-
sive state is associated with a deficiency of circulating brain 
NP levels.25 Interestingly, low plasma levels of NPs have 
been identified as a common predisposition for metabolic 
and cardiovascular diseases.19 In line with data from hyper-
insulinemic rats displaying a hypertensive phenotype,26 we 
showed that in RictoraP2KO mice hyperinsulinemia is associ-
ated with increased HR and blood pressure. Thus, high levels 
of insulin and its strong variability during the course of the 
day might disable appropriate diurnal blood pressure regu-
lation and reduce expression of Anp and Bnp in RictoraP2KO 
mice. Studying other pathophysiological mechanisms of 
hypertension,27 such as the activation of the renin–angioten-
sin aldosterone system and the sympathetic nervous system, 
and changes in salt sensitivity was beyond the scope of this 
study. Particularly, the possible impact of angiotensin II on 
the regulation of insulin-dependent AKT activation war-
rants further investigation because angiotensin II plays a 
major role in the pathogenesis of insulin resistance and in the 
Figure 5. Steady-state mRNA expression levels of core clock 
genes are different in perivascular adipose tissue (PVAT) from 
Rictor knockout (RictoraP2KO) mice during the light period. mRNA 
expression levels of core clock genes in PVAT were determined 
using quantitative RT-PCR. Gray shaded areas represent the 12 
hour dark period. Values are expressed in arbitrary units (AU). 
n=3 per group and time point. *P<0.05, **P<0.01, ***P<0.005, 
#P=0.06, and §P=0.08 vs control.
Figure 6. Deletion of Rictor does not affect core clock gene 
expression in the suprachiasmatic nucleus. mRNA expression 
levels of core clock genes in the suprachiasmatic nucleus (SCN) 
of Rictor knockout (RictoraP2KO) and control mice were analyzed 
using quantitative RT-PCR. Gray shaded areas represent the 12 
hour dark period. Values are expressed in arbitrary units (AU). 
n=3/5 per group and time point.
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diurnal regulation of blood pressure.28 We focused on loco-
motor activity, another important factor that can influence HR 
and blood pressure.17 Locomotor activity was sustained and 
high in RictoraP2KO mice during the dark period, which could 
explain in part the strong impairment of the physiological 
decline of MAP in RictoraP2KO mice.
We also investigated the deletion of Rictor in different 
organs in more detail, based on the fact that the tissue specific-
ity of the aP2 gene promoter used to produce the conditional 
knockout may not be restricted to adipocytes.8,29 Interestingly, 
activity of the aP2 promoter–driven CRE recombinase in the 
brain was established8,29 and confirmed by our data. Using 
the brain-specific nestin promoter to drive CRE expression in 
floxed Rictor mice, Thomanetz et al30 demonstrated that brain 
size was reduced by about 40% compared with controls. We 
found a 17% reduction in brain size in RictoraP2KO mice, indi-
cating that different approaches to target Rictor in the brain 
may result in brain size reduction of variable magnitude.30 
The current approach to knockout Rictor resulted in a 50% 
to 75% reduction of Rictor gene expression in adipose tis-
sues and brain. Therefore, we considered a potential impact 
of Rictor deletion in the brain, particularly in the SCN where 
the biological master clock is located to alternatively explain 
the observed changes in daily rhythmicity of blood pressure 
and locomotor activity in RictoraP2KO mice. Tightly regulated 
clock genes control daytime-dependent behaviors and mam-
malian physiology.31 Mutations and deletions of clock genes 
in mice have been associated with changes in blood pressure 
and its diurnal patterns.32 In the SCN, diurnal expression 
of core clock genes remained unaltered during the 24-hour 
cycle. These results imply that changes in blood pressure 
and locomotor activity observed in RictoraP2KO mice are reg-
ulated downstream or independently of the molecular clock 
mechanism in the SCN. Thus, the present data underpin the 
importance of the exact tuning of Rictor expression in the 
brain–adipose axis to ensure daily oscillation of physiological 
processes. The impact of Rictor deletion in other brain regions 
possibly influencing the observed phenotype of RictoraP2KO 
mice needs further investigation.
In contrast, genome-wide mRNA expression analy-
sis revealed a significant impact of Rictor deletion on 
peripheral clock gene expression in PVAT. Further analy-
sis during a 24-hour cycle revealed significantly reduced 
expression of clock genes Rorα, Per1, Cry1, and Clock and 
Per2 phase-shift in PVAT of RictoraP2KO mice. Interestingly, 
Rorα and Per1/Per2 have been shown to contribute to the 
regulation of inflammatory processes in the cardiovascular 
system33 and in the adipose tissue.34 Decreased expression 
of Per1/2, Cry1, and Clock was shown in inflamed epi-
didymal adipose tissue of genetically obese ob/ob mice.34 
Thus, reduced Rorα, Per1, Cry1, and Clock gene expres-
sion might facilitate the proinflammatory molecule expres-
sion in RictoraP2KO mice which we observed previously7 and 
increase in blood pressure.
Perspectives
In summary, this study establishes the importance of RICTOR/
mTORC2 in the regulation of the interactions between vascu-
lature, adipocytes, and brain to tune oscillatory physiological 
outcomes, such as blood pressure and locomotion. These inter-
actions are likely to be mediated by hormones, such as insulin 
and NPs. Further experiments are needed to elucidate these 
complex relationships which might give hints for effective 
strategies to combat prehypertensive conditions in patients.
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What Is New?
•	RICTOR in adipose tissue and brain contributes to the regulation of blood 
pressure and locomotion.
•	RICTOR stabilizes diurnal fluctuations of clock gene expression and af-
fects cell density in perivascular adipose tissue, but has no impact on 
clock genes in the suprachiasmatic nucleus.
•	Gene expression of natriuretic peptides and their receptors is reduced in 
the heart and adipocytes of RictoraP2KO mice.
What Is Relevant?
•	Reduced Rictor expression may be a key event during prehypertension in 
patients facilitating progression of the disease by increasing perivascular 
adipose tissue inflammation and by dampening of the protective signal-
ing of natriuretic peptides.
•	RICTOR in the brain–adipocyte axis contributes to the regulation of fluc-
tuating physiological functions, such as blood pressure and locomotion.
Summary
At the tissue level, aP2 gene promoter–driven CRE recombinase 
expression to ablate Rictor gene expression results in a higher cell 
density and impaired daily fluctuations of core clock genes in peri-
vascular adipose tissue.
At the whole body level, RICTOR/mTORC2 in adipose tissue and 
brain modulates diurnal fluctuations in blood pressure and locomo-
tion and results in a smaller brain. The underlying mechanism pos-
sibly involves impaired perivascular adipose tissue function, induc-
tion of hyperinsulinemia, and reduced natriuretic peptide signaling.
Novelty and Significance
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1. Methods 
Mice and tissue collection 
Mice used in the present study were described in detail before 1. Briefly, mice with 
deletion of Rictor (RictoraP2KO) were generated by crossing Rictorfl/fl mice with 
C57BL/6J mice expressing CRE recombinase under the control of the adipocyte 
protein 2 (aP2, also known as fatty acid binding protein 4) gene promoter (purchased 
from JAX Laboratories, Bar Harbor, Maine, USA). In all experiments, male mice (18-
23 weeks old) were used and as control group, littermates without the Cre transgene 
(Rictorfl/fl, termed henceforth control). 
Mice were kept in the institutional animal facilities (University of Zurich and University 
Hospital of Zurich, Switzerland) at 22 °C with a 12:12 hour light/dark cycle. Light 
onset was at 7 am [zeitgeber time (ZT) 0] and light offset was at 7 pm (ZT 12). 
Animals had access to standard chow (4.5 % calories from fat; Kliba Nafag, 
Kaiseraugust, Switzerland) and water ad libitum. All mice used were genotyped for 
Rictor (standard PCR) and Cre recombinase (quantitative RT-PCR) using specific 
mouse primers (Table S5) and standard protocols (JAX Laboratories, Bar Harbor, 
Maine, USA). Before sacrifice, mice were weighed and anesthetized by 
intraperetoneal (i.p.) injection (xylazine: 20; ketamine: 100; and acepromazine: 3.0; in 
mg/kg body weight) and exsanguinated via cardiac puncture. Mice used for 
confirmation of the Rictor knockout in PVAT and aortas (aortic tissue) and for the 
genome expression study were starved overnight and sacrificed at 9 am.  
All mouse experiments described here were approved by the Kantonales 
Veterinaeramt of Zurich, Switzerland (License numbers ZH44/2011 and 
ZH184/2014). Therewith, the investigation conforms to the Guide for the Care and 
Use of Laboratory Animals published by the US National Institutes of Health (8th 
Edition, 2011).  
 
Isolation of T cells and monocytes using fluorescence activated cell sorting 
Freshly isolated spleens were passed through 70 µm and 40 µm cell strainers in 
order to obtain single cell suspension. Erythrocytes were depleted by 2 minute 
incubation in ACK buffer. Cells were incubated with the appropriate combination of 
fluorochrome-conjugated antibodies: anti-CD4 (clone RM4-4), anti-CD11c (N418, 
both eBioscience), anti-I-A/I-E (2G9, BD Bioscience), anti-CD11b (M1/70), anti-CD3 
(17A2), and anti-Ly6C (HK1.4, all Biolegend). CD3+CD4+ splenocytes were identified 
as CD4+ T lymphocytes cells and CD11b+CD11c−MHC-II−Ly-6Chi splenocytes as 
inflammatory monocytes. Propidium iodide (PI, eBioscience) was used to exclude 
dead cells. Cells were sorted with FACSAria III (BD Bioscience).  
Tissue collection and histological analysis 
For analysis of tissues during a 24 hour period, 3 mice from each group were 
sacrificed every 4 hours and different tissues from control and RictoraP2KO mice were 
collected. The first mouse groups were sacrificed at 9 am (ZT 2), 2 hours after light 
onset. For tissue collection during the dark period, mice were euthanized under red 
light to ensure no disruption of the 12:12 hour light/dark cycle. Mice were not starved 
before sacrifice.  
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After euthanasia, body weights were collected at necropsy to allow calculation of 
organ to body weight ratios. A complete necropsy, including a thorough external and 
internal gross post mortem examination was performed on each mouse. Heart and 
brain from each mouse were excised, dried on filter paper and weighed. Mouse heart 
weights were normalized to body weights (HW/BoW). Representative samples of all 
organs and tissues were harvested and fixed in 10 % neutral buffered formalin. 
PVAT was dissected from the thoracic aorta and aortic arch and tissues were 
immediately placed in RNAlater™ (Qiagen, Hilden, Germany) or directly snap-frozen. 
Blood collected in ethylenediamine tetraacetic acid (EDTA) tubes during 
exsanguination was centrifuged at 8000 x g for 15 min at 4 °C, plasma in the 
supernatant snap-frozen and kept with all the other collected tissues at  -80 °C until 
further analysis. 
After routine paraffin wax embedding, sections (3-5 μm) were prepared and stained 
with haematoxylin and eosin (HE). Histological analysis was performed on the heart, 
aortic arch, lungs and kidneys. Three cross sections were obtained from each heart 
at standard distances from the apex, to visualize the left and right ventricles. The 
Masson’s Trichrome stain was applied for the visualization of collagen fibers in the 
heart and lungs 2. All slides were scanned using digital slide scanner NanoZoomer-
XR C12000 (Hamamatsu, Japan) and images were taken using NDP.view2 viewing 
software (Hamamatsu, Japan). Cross sectional lengths of the septal wall and right 
and left ventricular free walls were measured. 
Cardiomyocyte cross‐sectional area was employed as index of cardiac hypertrophy. 
Periodic acid-Schiff (PAS) staining on 3-5 µm heart sections was applied to better 
outline the cardiomyocyte boundaries and quantify cardiomyocyte cross‐sectional 
area. Scanned slide images were taken as mentioned above. In all mice, 
measurements were taken from the outline of 50 randomly selected cardiomyocytes 
exhibiting a clear cross‐cut nucleus. Measurements were done using ImageJ 1.48 
software (http://imagej.nih.gov/ij/index.html). 
 
Recording of blood pressure and locomotor activity in mice using 
radiofrequency transmitters 
Control and RictoraP2KO mice (n=5-6 per group) were implanted with a telemetry 
sender (TA11PA‐C10, Data Sciences International, St. Paul, MN, USA) via the left 
carotid artery to monitor simultaneously mean (MAP), diastolic (DAP) and systolic 
arterial pressure (SAP), pulse pressure, heart rate (HR), and locomotor activity. 
Operation and post-operative care procedures were described previously 3. Briefly, 
mice were anesthetized with isoflurane, and the telemetry sender implanted in the left 
carotid artery. The transmitter, connected with the telemetry sender via a small 
catheter, was positioned under the skin between the right front and hind limb. Mice 
were kept warm on a heating pad and monitored until fully recovered from 
anesthesia. After surgery, mice were single caged in a warming cabinet at 30 °C in a 
12:12 hour light/dark cycle with access to food and water ad libitum. Recovery from 
surgery was allowed for 7 days before measurements were started. During 
measurement, mice were housed individually and the temperature in the warming 
cabinet was adjusted to 25 °C. Blood pressure and locomotor activity data were 
determined from day 8 after surgery during the following week up to three weeks post 
telemetry sender implantation. Data from each telemetry sender were transmitted to 
a receiver plate (RPC‐1, Data Sciences International, St. Paul, USA) positioned 
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below each cage and thereafter collected using the Dataquest A.R.T. system, version 
4.2 (Data Sciences International, St. Paul, USA). Blood pressure was measured for 
30 seconds every 5 minutes. Locomotor activity was recorded continuously by the 
frequency of movement of each animal across the cage in counts/min (intensity of 
activity). For analysis of locomotor activity, less than 0.6 counts per minute were 
considered as inactive and set to 0 for further calculations. 
 
RNA isolation, reverse transcription and quantitative real-time PCR  
RNA from PVAT, EFAT and adipocytes was extracted using RNeasy® lipid tissue kit, 
from thoracic aortas, and heart using RNeasy® fibrous tissue kit, from kidney, liver 
and stromal vascular fraction using RNeasy® mini kit, and T cells and monocytes 
using RNeasy® plus mini kit according to the protocol of the manufacturer (Qiagen, 
Hombrechtikon, Switzerland) respectively, including an on-column DNase digestion 
(RNase-free DNase, Qiagen). Before reverse transcription, RNA quantity and quality 
was determined using Nanodrop 2000 Spectrophotometer and Agilent 2100 
Bioanalyzer. Reverse transcription of 50 ng RNA from PVAT, stromal vascular 
fraction and thoracic aortas was performed using WT (Whole Transcript)-Ovation® 
Pico RNA Amplification System (Nugen, Bemmel, Netherlands) and from EFAT, 
adipocytes, heart, kidney, liver, T cells and monocytes using iScript™ Reverse 
Transcription Supermix according manufactures recommendations (BioRad, 
Hercules, CA, USA). For quantitative RT-PCR, final cDNA concentration was 
adjusted to 10 ng in a 15 µl reaction volume. Each reaction was performed in 
duplicates using Bio-Rad CFX96 Real-Time System and iQ™ SYBR® Green 
Supermix (BioRad, Hercules, CA, USA) and specific mouse primers. Gene 
expression in PVAT, thoracic aortas, EFAT and adipocytes was normalized to the 
reference gene acidic ribosomal phosphoprotein (Arbp), in heart, kidney and liver to 
the reference gene cyclophelin B and in the stromal vascular fraction to the reference 
gene TATA box binding protein (Tbp) using the comparative C(T) method 4. If not 
otherwise noted, mouse primer pairs for selected genes were designed using Primer 
Blast (NCBI, USA) 5 and are listed in supplementary method Table S4. 
 
Isolation of RNA from suprachiasmatic nucleus and brain cortex 
The brain was dissected, placed in artificial cerebrospinal fluid (ACSF; NaCl - 120 
mM; KCl - 2.5 mM;  MgCl2 x 6*H2O - 1 mM; NaH2PO4 x 2*H2O; - 1.25 mM; NaHCO3 - 
26 mM; HEPES - 5 mM; CaCl2 - 2 mM; glucose - 16 mM; pH 7.35) and 250 to 300 
µm brain slices were cut using a vibratom (Leica VT 1200, Leica Biosystems, 
Switzerland). Brain regions containing the SCN and cortex were identified under a 
binocular (Olympus SZ61, Volketswil, Switzerland), cut out, and stored at - 80°C until 
further analysis. SCN and cortex were homogenized in 300 µl RLT-buffer with β-
mercaptoethanol by vortexing the samples 3 x 10 sec at room temperature. RNA was 
extracted using RNeasy® micro kit according the recommendations of the 
manufacturer (Qiagen, Hombrechtikon, Switzerland). 5 µl eluat from the isolation 
columns were reversed transcribed to cDNA using WT (Whole Transcript)-Ovation 
Pico RNA Amplification System (Nugen, Bemmel, Netherlands). cDNA transcription 
and quantitative RT-PCR were performed as described above and relative gene 
expression levels were normalized to glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh). 
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Bioplex analysis 
Bioplex assay was performed using blood plasma collected from control and 
RictoraP2KO mice. Concentrations of insulin were measured using corresponding 
components of BioPlex™ Pro Mouse Diabetes assay according to the manufacturer’s 
protocol in a Bioplex™ 100 machine (BioRad, Hercules CA, USA). Data were 
analyzed using BioPlex™ Manager 4.1.1 software and quantified based on the 
Logistic-5PL regression standard curve.  
 
Glucose levels in blood plasma 
Plasma glucose levels were determined in RictoraP2KO and control mice using UniCel 
DxC 800 System and specific reagent, calibration and control kits for glucose 
measurement (Beckman Coulter, Galway, Ireland) according to the manufacturer’s 
recommendations.  
 
Histology of thoracic aorta and PVAT 
10 µm cross sections from thoracic aortas with PVAT were cut as described 
previously 6. Prior to staining, slides were dried for 20 min at room temperature, fixed 
in 4 % PFA in PBS (pH 7.4) for 10 minutes and washed twice for 5 min in aqua-dest. 
Haematoxylin staining was performed using Mayer’s haematoxylin (Dako, Baar, 
Switzerland) for 3-5 min followed by a 5 min washing step under slowly running tap 
water. For differentiation, slides were dunk twice in acidic alcohol (0.3 % HCl in 70 % 
EtOH) and washed immediately in aqua dest. For eosin staining, slides were 
incubated 30 sec in 0.1 % Eosin (Sigma, Buchs, Switzerland) washed immediately in 
deionized water and differentiated in 70 % Ethanol for 3 sec. Slides were washed 
twice for 2 min in deionized water and air dried. Coverslips were mounted with Eukit 
quick-hardening mounting medium (Sigma, Buchs, Switzerland) onto slides. 
Staining of the nuclei using Hoechst: Fixed cross-sections were incubated for 60 min 
with blocking buffer (5 % goat serum in PBS / 0.1 % TWEEN). Slides were washed 
twice for 5 min with PBS (pH 7.4) and nuclei were stained with Hoechst (2 µg/µL in 
PBS, pH 7.4, Life Technologies) for 5 min. Slides were washed 3 x 5 min with PBS 
(pH 7.4) and mounted with fluorescent mounting medium (Dako, Baar, Switzerland). 
Slides were dried at least 1 day before imaging. Images were acquired using CLSM 
Leica SP5 microscope and LAS-AF 2.6.3.8173 software (Leica, Heerbrugg, 
Switzerland). Nuclei were counted using image J 1.48 for Windows (NIH, USA) in a 
475 x 340 µm area. 
 
Whole-genome expression study  
Total RNA was isolated from PVAT surrounding the thoracic part of the arterial tree 
from control and RictoraP2KO mice. Total RNA was extracted using the RNeasy® lipid 
tissue kit according manufacturer’s recommendation (Qiagen, Hombrechtikon, 
Switzerland). DNase digestion of isolated total RNA was performed in solution 
(RNase-free DNase, Qiagen), followed by an additional purification step of total RNA 
using RNeasy® mini kit according manufactures protocol (Qiagen, Hombrechtikon, 
Switzerland). Before further analysis, RNA quality and quantity was determined using 
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Nanodrop 2000 Spectrophotometer and Agilent 2100 Bioanalyzer. Only total RNA 
with an RNA integrity number (RIN) > 8 were considered for further analysis.  
Total RNA was reverse transcribed and cDNA amplified using Ambion® WT 
Expression kit (Affymetrix, United Kingdom) following manufacturer's protocols. 
Biotinylated cDNA was prepared using Encore Biotine Module (Nugen, Netherlands) 
according to manufacturer's recommendations and hybridized to Affymetrix Mouse 
Gene® 1.0 ST array strips (Affymetrix, Santa Clara, CA). Gene Chips were scanned 
using the Hewlett-Packard GeneArray Scanner G2500A (Hewlett-Packard, 
Böblingen, Germany) and expression data analysed with Affymetrix Power Tools 
v1.10.2 (Affymetrix, Santa Clara, CA) using the RMA algorithm. The data discussed 
in this publication have been deposited in NCBI's Gene Expression Omnibus 7 and 
are accessible through GEO Series accession number GSE67077 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&acc=GSE67077). 
For further data analysis, genes were considered to be differentially expressed in 
RictoraP2KO mice if P<0.05 and fold change > 1.5. A gene ontology analysis was 
performed with genes identified using GeneGo Analysis program (www.genego.com).  
 
Statistical analysis 
Data are expressed as means ± standard error of the mean (SEM) or as box blots in 
which the median is represented by a horizontal line. To this end, data from each 
mouse were compiled to one data point (mean) and are represented in box blots 
according to the mouse groups. Comparisons between groups for other experiments 
were analyzed by two-tailed Student’s t-test. For displaying MAP, levels of locomotor 
activity and heart rate over time, we used running medians to smooth data. 
Differences were considered statistically significant at values of P<0.05. Statistical 
analyses were performed using GraphPad Prism 5.04 program for Windows 
(GraphPad software, SanDiego, CA, USA) and R for Windows (R Core Team 2014). 
R: A language and environment for statistical computing (R Foundation for Statistical 
Computing, Vienna, Austria. URL http://www.R-project.org/). 
 
 
 
  
  Online Supplement: Drägert et al.,  
7 
 
2. References 
1. Cybulski N, Polak P, Auwerx J, Ruegg MA, Hall MN. Mtor complex 2 in 
adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S 
A. 2009;106:9902-9907. 
2. Luna L. Manual of histologic staining methods of the armed forces institute of 
pathology. McGraw-Hill, NY. 1968;3rd edition:94-95. 
3. Schuler B, Rettich A, Vogel J, Gassmann M, Arras M. Optimized surgical 
techniques and postoperative care improve survival rates and permit accurate 
telemetric recording in exercising mice. BMC veterinary research. 2009;5:28. 
4. Schmittgen TD, Livak KJ. Analyzing real-time pcr data by the comparative c(t) 
method. Nat Protoc. 2008;3:1101-1108. 
5. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-
blast: A tool to design target-specific primers for polymerase chain reaction. 
BMC bioinformatics. 2012;13:134. 
6. Bhattacharya I, Dragert K, Albert V, Contassot E, Damjanovic M, Hagiwara A, 
Zimmerli L, Humar R, Hall MN, Battegay EJ, Haas E. Rictor in perivascular 
adipose tissue controls vascular function by regulating inflammatory molecule 
expression. Arterioscler Thromb Vasc Biol. 2013;33:2105-2111. 
7.  Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene 
expression and hybridization array data repository. Nucleic Acids Res. 2002; 
30:207-210. 
8. Kreusser MM, Lehmann LH, Keranov S, Hoting MO, Oehl U, Kohlhaas M, Reil 
JC, Neumann K, Schneider MD, Hill JA, Dobrev D, Maack C, Maier LS, Grone 
HJ, Katus HA, Olson EN, Backs J. Cardiac cam kinase ii genes delta and 
gamma contribute to adverse remodeling but redundantly inhibit calcineurin-
induced myocardial hypertrophy. Circulation. 2014;130:1262-1273. 
9. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessi-Fulgheri P, Zhang C, 
Takahashi N, Sarzani R, Collins S. Cardiac natriuretic peptides act via p38 
mapk to induce the brown fat thermogenic program in mouse and human 
adipocytes. J Clin Invest. 2012;122:1022-1036. 
 
 
 
 
 
 
 
 
  Online Supplement: Drägert et al.,  
8 
 
3. Supplementary Tables and Figures: 
 
    
 
Hemo-
dynamic 
Parameters 
 
Control  
 
    Light            Dark          24 hour 
 
 
    Rictor
aP2KO 
 
    Light            Dark               24 hour 
 
MAP, mm Hg  94.4±1.5 102.6±1.3 98.5±1.4 99.1±1.0 108.7±1.5* 103.9±1.1* 
DAP, mm Hg  86.5±0.5 94.0±0.7 90.2±0.6 89.9±1.0*   99.4±2.0*   94.6±1.4* 
SAP, mm Hg 102.6±2.7 111.4±2.5 107.0±2.6 107.4±1.9 117.2±1.7 112.3±1.7 
PP, mm Hg 16.1±2.7 17.3±2.9 16.7±2.8 17.5±2.2   17.8± 2.2  17.7±2.2 
HR, BPM 400.3±4.4 445.7±5.0 423.0±4.5 418.8±11.9 495.8±11.9** 457.3±10.4* 
       
 
 
Table S1: Summary of the hemodynamic parameters recorded in control and 
Rictor
aP2KO
 mice during the 12 hour light period, 12 hour dark period and the 12:12 
hour light/dark cycle. Values represent arithmetic means ± SEM derived from 7 days 
of continuous measurement. n=5/6. *P<0.05 and **P<0.01 versus control.  
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Control  
 
Light           Dark      24 hour 
 
Rictor
aP2KO 
 
Light         Dark        24 hour 
 
Intensity of activity, 
counts/min 2.0 ±0.2
 6.2±0.7 4.1±0.5 4.2±1.1 10.5±2.4 7.4±1.7 
Active time, % 
 
 
19.6±2.3 
 
 
47.1±2.3 
 
 
33.4±2.2 
 
 
33.5±5.6* 
 
 
68.7±4.7** 
 
 
51.1±5.0* 
 
Table S2: Summary of intensity of activity and percentage of active time 
in control and Rictor
aP2KO
 mice during the 12 hour light period, 12 hour 
dark period and 12:12 hour light/dark cycle. Values represent arithmetic 
means ± SEM derived from 7 days of a continuous measurement. n=5/6. 
*P<0.05, **P<0.01 versus control. 
Locomotor 
Parameters  
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Process  
GeneGO analysis –  
Pathways Maps 
Total-No.  
of genes 
Genes changed in 
Rictor
aP2KO
 
P-Value 
1 
 
 
Neurophysiological process –  
Circadian rhythm 
 
47 
Bmal1, Dec1, 
Cry1, Rev-Erbα, 
Npas2 
2.051E-07 
2 
 
Cholesterol Biosynthesis 
 
88 
Nsdhl, Cyp51A1, 
Fdps 
2.103E-03 
3 
 
Regulation of lipid metabolism - 
Regulation of lipid metabolism 
via LXR, NF-Y and SREBP 
 
38 Cyp51A1, Ldlr 5.492E-03 
4 
 
Protein folding and maturation - 
Angiotensin system maturation 
/ Rodent version 
 
48 Mc-cpa, Mcpt4 8.655E-03 
5 
Development - TGF-beta 
receptor signalling 
 
 
50 
Pai1, Gadd45 
beta 
9.366E-03 
6 
 
Cytoskeleton remodeling  
 
102 Melc, Pai1 3.588E-02 
Table S3: Gene ontology analysis of micro array data revealed a significant 
impact of Rictor deletion in adipocytes on clock gene expression in PVAT 
from Rictor
aP2KO
 mice.  
Gene ontology analysis of 68 differentially expressed genes (P<0.05; fold change 
> 1.5) was performed using GeneGo analysis program (www.genego.com). Most 
genes were assigned to networks involved in circadian rhythm, lipid 
synthesis/metabolism and cytoskeletal remodelling. 
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Probe 
Name Accession Gene Symbol Gene Name Log2 ratio ratio
 P-Value 
10404389 NM_013674 Irf4 interferon regulatory factor 4 1.469 2.768 0.02768 
10362420 NM_029726 Trdn Triadin 1.257 2.39 1.12E-05 
10345675 NM_008719 Npas2 neuronal PAS domain protein 2 1.233 2.35 0.003811 
10410388 AK149411 E430024C06Rik RIKEN cDNA E430024C06 gene 1.07 2.099 0.0008981 
10362428 NM_029726 Trdn Triadin 1.037 2.052 0.00779 
10420247 NM_010779 Mcpt4 mast cell protease 4 0.9781 1.97 0.009402 
10474972 NM_026929 Chac1 ChaC, cation transport regulator-like 1 (E. coli) 0.9555 1.939 0.03205 
10371400 NM_007771 Cry1 cryptochrome 1 (photolyase-like) 0.9347 1.911 0.02016 
10409278 NM_017373 Nfil3 nuclear factor, interleukin 3, regulated 0.8999 1.866 0.01812 
10417371 
NM_001024712 
NM_100042149 
Gm3696;  
Gm2897 
predicted gene 3696 
predicted gene 2897 
0.7937 1.734 0.002434 
10497451 NM_007753 Cpa3 carboxypeptidase A3, mast cell 0.733 1.662 0.02231 
10516932 NM_144907 Sesn2 sestrin 2 0.7301 1.659 0.01513 
10458555 NM_011898 Spry4 sprouty homolog 4 (Drosophila) 0.6833 1.606 0.004955 
10419156 
NM_053112 
  
NM_007895 
NM_007894 
NM_001012766.1 
NM_017388.1 
Ear10 
Ear2 
Ear1 
Ear12 
Ear3 
eosinophil-associated, ribonuclease A family, 
member 10 
eosinophil-associated, ribonuclease A family, 
member 2 
eosinophil-associated, ribonuclease A family, 
member 1 
eosinophil-associated, ribonuclease A family, 
member 12 
eosinophil-associated, ribonuclease A family, 
member 3 
0.6264 1.544 0.03445 
10556463 NM_007489 Arntl 
aryl hydrocarbon receptor nuclear  
translocator-like 
0.6218 1.539 0.0007209 
10542885 NM_026054 2810474O19Rik RIKEN cDNA 2810474O19 gene 0.6178 1.535 0.01522 
10552143 
NM_017394  
NM_001024707 
Slc7a10 
Lrp3 
solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 10; 
low density lipoprotein receptor-related protein 
3 
0.6174 1.534 0.02518 
10436890 ENSMUST00000114029 Gm10785 predicted gene 10785 0.6097 1.526 0.0004848 
10466304 NM_172442 Dtx4 deltex 4 homolog (Drosophila) 0.6033 1.519 0.002598 
10461614 NM_028595 Ms4a6c membrane-spanning 4-domains, subfamily A, member 6C 0.6029
 1.519 0.004982 
10399666 ENSMUST00000101538 9030624G23Ri 
RIKEN cDNA 9030624G23 gene; similar to 
development and differentiation enhancing  
factor 2 
0.5981 1.514 0.0001629 
10407124 ENSMUST00000099179 AI452195 expressed sequence AI452195 0.5882 1.503 0.02528 
10450784 NM_008205 H2-M9 histocompatibility 2, M region locus 9 0.585 1.5 0.02428 
Table S4: Micro Array analysis revealed 68 genes to be differentially expressed 
in PVAT of Rictor
aP2KO
 mice compared with controls.  
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Probe 
Name Accession 
Gene 
Symbol Gene Name Log2 ratio ratio P-Value 
10349694 NM_178079 Pm20d1 peptidase M20 domain containing 1 -0.5872 0.6656 0.01873 
10588691 
NM_008317 
NM_019750.3 
Hyal1 
Nat6 
hyaluronoglucosaminidase 1 
N-acetyltransferase 6 
-0.5907 0.664 0.03446 
10527920 NM_020010 Cyp51 cytochrome P450, family 51 -0.5943 0.6624 0.006773 
10499483 NM_134469 Fdps farnesyl diphosphate synthetase -0.597 0.6611 0.0005444 
10488762 NM_009228 Snta1 syntrophin, acidic 1 -0.6033 0.6582 0.0006908 
10399588 AJ005350 Zfp125 zinc finger protein 125 -0.6039 0.658 0.004791 
10441774 NM_013667 Slc22a2 solute carrier family 22 (organic cation transporter), member 2 -0.6118
 0.6544 0.02106 
10480725  BC029214 cDNA sequence BC029214 -0.6134 0.6537 0.01623 
10347224 NR_004414 Rnu2-10 Mus musculus U2 small nuclear RNA 10 (Rnu2), small nuclear RNA -0.631
 0.6457 0.003555 
10379650 AF099974 Slfn3 schlafen 3 -0.631 0.6457 0.003555 
10373400 NM_172259 Myl6b myosin, light polypeptide 6B -0.6414 0.6411 0.04055 
10347222 NR_004414 Rnu2-10 Mus musculus U2 small nuclear RNA 10 (Rnu2), small nuclear RNA -0.6423 0.6407
 0.004084 
10600082 NM_010941 Nsdhl NAD(P) dependent steroid dehydrogenase-like -0.6434 0.6402 0.01017 
10467319 NM_011255 Rbp4 retinol binding protein 4, plasma -0.6646 0.6309 0.03843 
10532828 NM_029956 Mmab methylmalonic aciduria (cobalamin deficiency) type B homolog (human) -0.6656
 0.6304 0.03463 
10603736 NR_004414 Rnu2 U2 small nuclear RNA -0.6677 0.6295 0.007948 
10553354 NM_175272 Nav2 neuron navigator 2 -0.6863 0.6214 0.008013 
10578688 NR_004414 Rnu2 U2 small nuclear RNA -0.7014 0.615 0.007011 
10373000 NM_026858 Xrcc6bp1 XRCC6 binding protein 1 -0.7098 0.6114 0.00352 
10477649 NM_019811 Acss2 acyl-CoA synthetase short-chain family member 2 -0.7105 0.6111 0.008286 
10469151 NM_172471 Itih5 inter-alpha (globulin) inhibitor H5 -0.7122 0.6104 0.03679 
10551966 NM_001012401 Hspb6 heat shock protein, alpha-crystallin-related, B6 -0.717 0.6084 0.005251 
10583732 NM_010700 Ldlr low density lipoprotein receptor -0.7182 0.6079 0.004846 
10540472 NM_011498 Bhlhe40 basic helix-loop-helix family, member e40 -0.7384 0.5994 0.04434 
10553092 
NM_016974 
NM_203280 
Dbp 
Sphk2 
D site albumin promoter binding protein 
sphingosine kinase 2 
-0.7553 0.5924 0.0003359 
10585398 NM_177350 Gldn gliomedin -0.7827 0.5813 0.04205 
10381460 NR_004414 Rnu2 U2 small nuclear RNA -0.7874 0.5794 0.003409 
10381470 NR_004414 Rnu2 U2 small nuclear RNA -0.7874 0.5794 0.003409 
10381472 NR_004414 Rnu2 U2 small nuclear RNA -0.7874 0.5794 0.003409 
10391488 NR_004414 Rnu2 U2 small nuclear RNA -0.7874 0.5794 0.003409 
10381458 NR_004414 Rnu2 U2 small nuclear RNA -0.8027 0.5733 0.003953 
10579165 NM_007789 Ncan neurocan -0.8833 0.5421 0.02653 
10417734 NM_011584 Nr1d2b nuclear receptor subfamily 1, group D, member 2 -0.9939 0.5021 0.001567 
10364149 NM_009115 S100b S100 protein, beta polypeptide, neural -1 0.4999 0.01672 
10502949 ENSMUST00000083804 snoRNA snoRNA -1.067 0.4773 0.0002746 
10534667 NM_008871 Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 -1.108
 0.4639 0.006309 
10560481 NM_008036 Fosb FBJ osteosarcoma oncogene B -1.126 0.4582 0.001421 
10390691 
NM_145434 
NM_178060  
Nr1d1a 
Thra 
nuclear receptor subfamily 1, group D 
thyroid hormone receptor alpha 
-1.255 0.419 0.0217 
10364950 NM_008655 Gadd45b growth arrest and DNA-damage-inducible 45 beta -1.36 0.3897 0.009499 
 
 
 
Continued table S4 
 
Continued table S3 
Micro array was performed using cDNA transcribed from RNA of PVAT from Rictor
aP2KO
 mice 
and controls and Affymetrix Mouse Gene 1.1 ST array Strips. Expression data were analyzed 
with Affymetrix Power Tools v1.10.2 (Affymetrix, Santa Clara, CA) using the RMA algorithm. 
Differentially expressed genes were ranked in accordance to the fold change (P<0.05) in 
descending order. 
a
= also known as Rev-Erbα; 
b
= also known as Rev-Erbβ. 
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Table S5: Sequences of primer pairs used for standard and quantitative real-
time PCR. Primer pairs were designed using «primer blast» program (NCBI, USA) 5 
and are specific to mouse cDNA. Sequences for primer pairs specific for Anp, Npra, 
Nprc, α-Mhc and β-Mhc were already described 8,9.  
Gene name Forward Primer (5'-3') Reverse Primer (5'-3') 
Anp CAC AGA TCT GAT GGA TTT CAA GA CCT CAT CTT CTA CCG GCA TC 
Arbp AGCTGAAGCAAAGGAAGAGTCGGA ACTTGGTTGCTTTGGCGGGATTAG 
Bhlhe40 ACG TTG AAG CAC GTG AAA GC CTT CCC GAC AAA TCA CCA GC 
Bmal1 ACT ACA GTG GCC CTT TG CAT GCC CAA ATT CCC ACA TCT GAA G 
Bnp1 GTC TGG CCG GAC ACT CAG TGC ACT GGT GTC TTC AAC AAC 
Clock TTA GAT CAC AGG GCA CCA CC AGT GCT CGT GAC ATT TTG CC 
Cnp GAC ACC ACC GAA GGT CCC G CCT GGA GTC TTG TCA CCC TTT T 
Cre GCG GTC TGG CAG TAA AAA CTA TC ACC CGG CTG CTC TTA CTT CT 
Cry 1 ATG TCC CGA GTT GTA GCA GC  TGA GAG CAA TTT CCA CCG CT 
Cry 2 AGC TGA TGT GTT CCC AAG GCT CAT AAT GGC TGC ATC CCG TT 
Cyclophelin B GGT GGA GAG CAC CAA GAC AGA GCC GGA GTC GAC AAT GAT G 
Dbp GGA ACT GAA GCC TCA ACC AAT C CTC CGG CTC CAG TAC TTC TCA 
Gapdh AAA TGG TGA AGG TCG GTG TG GTT GAA TTT GCC GTG AGT GG 
Nfil3 GAG CAG AAC CAC GAT AAC CCA T TAC AGA CCG GAT GGA GGA GAC 
Npas2 AGA GGC AGC TTG AAC CCA AA  GAG GGG CTA GGC ACA TTG TT 
Npra CGA AGA CAA GTG CAT CCT GAG TGG AGA CAC AGT CAA CAC AGC 
Nprb ACC GGT CAC TTC AAG GGA AA GGC TCC GAT GAA GCG AGT AA 
Nprc AGC TGG CTA CAG CAA GAA GG CGG CGA TAC CTT CAA ATG TC 
Per1 CCA GAT TGG TGG AGG TTA CTG AGT GCG AGA GTC TTC TTG GAG CAG TAG 
Per2 AGA ACG CGG ATA TGT TTG CTG ATC TAA GCC GCT GCA CAC ACT 
Rev-Erb-α TGT CTA GAG ATG CTG TGC GTT T AGG CTG CTC AGT TGG TTG TT 
Rictor (PCR) TTA TTA ACT GTG TGT GGG TTG CGT CTT AGT GTT GCT GTC TAG 
Rictor (qRT-PCR)  TGC GAT ATT GGC CAT AGT GA  ACC CGG CTG CTC TTA CTT CT 
Rorα GCT TCT AAA AGC AGG CTC GC GGG ACT TGA AGA CAT CGG GG 
Tbp  GAG TTG CTT GCT CTG TGC TG  CTG GCT TGT GTG GGA AAG AT 
α-Mhc CGC ATC AAG GAG CTC ACC CCT GCA GCC GCA TTA AGT 
β-Actin  CGT GCG TGA CAT CAA AGA GA  CCC AAG AAG GAA GGC TGG A 
β-Mhc CGC ATC AAG GAG CTC ACC CTG CAG CCG CAG TAG GTT 
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Figure S1: Heart rate is increased and its physiological decline 
during the dark period nearly absent in Rictor
aP2KO
 mice. Heart 
rate (HR) was recorded over a period of 7 consecutive days in 
Rictor
aP2KO
 and control mice (n=5/6) kept in a constant 12:12 hour 
light/ dark cycle (light on: 7 am/ ZT 0; light off: 7 pm/ ZT 12). Diurnal 
fluctuations of HR are represented as one hour running median. 
Black bars at the bottom denote the 12 hour dark period.  
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Figure S2: Time courses of mean arterial pressure, heart rate and locomotor 
activity display similar patterns and are less steep in Rictor
aP2KO
 mice during the 
dark period. Intensity of activity, mean arterial pressure (MAP, A) and heart rate (HR, B) 
were recorded over a period of 7 consecutive days in Rictor
aP2KO 
and control mice (n=5/6) 
kept in constant 12:12 hour light/ dark cycles. Hourly means of the measured parameters 
at the indicated time points are represented. 
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Figure S3: aP2/CRE-driven deletion of Rictor affects cell density of aortic 
PVAT, while no differences in the heart and kidney are noted. Representative 
cross-sections stained with haematoxylin/eosin of (A) the heart, (B) the kidney, 
and (C) the aortic arch with PVAT are shown. Heart sections in A were performed 
at the level of the papillary muscles. Black bar: 2.5 mm. Grey bar: 500 µm. White 
bar: 500 µm. CO (cortex), ME (medulla), IVS (interventricular septum), LV (left 
ventricle), PM (papillary muscles), RV (right ventricle).  
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Figure S4: Strong variations in glucose and insulin 
plasma levels during a 24 hour cycle in Rictor
aP2KO
 
mice. (A) Insulin and (B) glucose concentrations were 
determined in blood plasma using BioPlex assay and 
UniCel DxC 800 System, respectively. Grey shaded 
areas represent the 12 hour dark period. ZT: Zeitgeber 
time. Values represent mean ± SEM. n=3. *P<0.05 
versus control.  
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Figure S5: Steady state mRNA expression levels of core clock 
genes are similar in aortic tissue from control and Rictor
aP2KO
 
mice. mRNA expression levels of core clock genes in aortic tissue 
were determined using qRT-PCR. Grey shaded areas represent the 
dark period. Values are expressed in arbitrary units (AU). n=3 per 
group and time point. *P<0.05 versus control.  
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